top of page

biologit News

biologit achieves ISO 27001 certification (information security)

biologit achieves ISO 27001 certification (information security)

biologit has obtained certification on the rigorous ISO 27001 information security standard.

To achieve ISO 27001 certification biologit has implemented robust processes and controls to manage and protect information assets effectively across the organization. With this milestone we continue to demonstrate our commitment to high security standards and being a trusted partner to our customers with our unique literature monitoring platform and service solutions.

biologit at Medtech Connect

biologit at Medtech Connect

Our CTO, Bruno Ohana will be speaking at the Medtech Rising conference, as part of MedTech Connect, happening on the 7th of December 2023 at the The Galmont Hotel, Galway, Ireland.

Medtech Connect is a showcase that provides Medtech SMEs a platform to raise awareness and exhibit their innovative technology solutions and business models to potential business partners, large MNCs or investors.

biologit: Machine learning and AI to monitor medical literature

biologit: Machine learning and AI to monitor medical literature

biologit is featured in Silicon Republic in the article “Machine learning and AI to monitor medical literature”, where co-founders Nicole Baker and Bruno Ohana discuss how the company is meeting the challenges of automating medical literature monitoring for pharmacovigilance and safety surveillance of medical devices, cosmetics and nutraceuticals.

Nicole Baker shortlisted for the Fifth AI Awards Ireland 2023

Nicole Baker shortlisted for the Fifth AI Awards Ireland 2023

biologit is proud to share that our CEO, Nicole Baker, is one of the four finalists in the "Woman AI Person of the Year" category for the 2023 annual AI Awards, sponsored by AI Ireland, taking place November, 21st in Dublin.

biologit at DIA Japan November 2023

biologit at DIA Japan November 2023

DIA Japan Annual Meeting 2023 is unique in presenting the entire healthcare value chain ranging from policy and regulations to R&D, marketing and access.

Held over three days under the theme of “Rebuilding Drug Development through Society 5.0", this edition of DIA represents a unique forum where every stakeholder is invited to discuss with their peers the future of drug development by combining the knowledge and skills of past, present, and future.

Connect with our team at the event 👇

bottom of page